In this video, recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Robert Figlin, MD, of Cedars-Sinai Medical Center, Los Angeles, CA, discusses the importance of sequential therapies in kidney cancer treatment. Immunotherapies and targeted agents are both mentioned, along with advice for practitioners who do not specialize in kidney cancer.
Optimizing treatment for renal cell carcinoma with sequential therapies
